Foxiga Korea Local Phase 4 Study

Clinical trial NCT02564926 · COMPLETED

Trial details

NCT number: NCT02564926
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2016-01-05
Primary completion: 2018-01-15
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.